David A Jans

InstitutionMonash University
AddressAustralia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 2 publications in April 2020
    All Publications
    Bar chart showing 187 publications over 20 distinct years, with a maximum of 16 publications in 2007
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Martin AJ, Jans DA. Antivirals that target the host IMPa/ß1-virus interface. Biochem Soc Trans. 2021 02 26; 49(1):281-295. PMID: 33439253.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    2. Jans DA, Wagstaff KM. The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ? Biochem Biophys Res Commun. 2021 01 29; 538:163-172. PMID: 33341233.
      Citations: 5     Fields:    Translation:Humans
    3. Jans DA, Wagstaff KM. Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal? Cells. 2020 09 15; 9(9). PMID: 32942671.
      Citations: 17     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    4. Bray M, Rayner C, Noël F, Jans D, Wagstaff K. Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses. Antiviral Res. 2020 06; 178:104805. PMID: 32330482.
      Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
    5. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 06; 178:104787. PMID: 32251768.
      Citations: 559     Fields:    Translation:HumansAnimalsCellsPHPublic Health